FARES II Cost-effectiveness analysis (LEX-211 Octapharma Original)
Clinical Trial Grant
Administered By
Anesthesiology, General, Vascular, High Risk Transplant & Critical Care
Awarded By
Octapharma AG
Start Date
February 25, 2026
End Date
February 9, 2027
Administered By
Anesthesiology, General, Vascular, High Risk Transplant & Critical Care
Awarded By
Octapharma AG
Start Date
February 25, 2026
End Date
February 9, 2027